Filing Flows › Zomedica (ZOMDF) › Q1 2026
Zomedica (ZOMDF) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 6, 2026
Zomedica (ZOMDF) reported revenue of $8.8M for the first quarter 2026 (Q1 2026), +35% from a year earlier and -16% from the quarter before. Operating margin was -55.7%, net loss $4.5M (51.5% of revenue).
Zomedica, Q1 2026: revenue $8.8M (+35% year over year), operating margin -55.7%, net loss $4.5M, operating cash flow −$5.3M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $8.8M | -16% | +35% |
| Operating profit | −$4.9M | — | — |
| Net earnings | −$4.5M | — | — |
| Operating cash flow | −$5.3M | — | — |
What changed
Revenue was $8.8M in Q1 2026, up 35% year over year and down 16% from the previous quarter. Consumables was the largest line at 62% of revenue. Consumables added $1.0M year over year (up 22%), 42% of the total change.
Gross margin was 62.3%, down 5.5 points from Q1 2025. Operating costs exceeded revenue by $4.9M, an operating margin of -55.7%. Operating expenses fell 85% while revenue rose 35%. The quarter ended with a net loss of $4.5M, wider than the previous quarter's $4.5M loss.
Operating cash flow was −$5.3M. Non-cash charges added back $1.9M of depreciation and amortization and $643K of share-based compensation. Working capital and other items used $3.3M. Capital expenditures of $60K exceeded it, leaving free cash flow of −$5.3M.
Questions
What was Zomedica's revenue in the first quarter 2026?
Zomedica (ZOMDF) reported revenue of $8.8M for the first quarter 2026 (Q1 2026), +35% from a year earlier and -16% from the quarter before.
Was Zomedica profitable in the first quarter 2026?
Operating loss was $4.9M (-55.7% of revenue) and net loss $4.5M.
Source: Zomedica 10-Q on SEC EDGAR.